- Fund Type: Open-End Fund
- Objective: -
- Asset Class: -
- Geographic Focus: Israel
Harel 4B Equity Track
+ Add to WatchlistBTSHARS:IT
217.95 ILs 0.09 0.04%As of 00:59:30 ET on 06/18/2013.
Snapshot for Harel 4B Equity Track (BTSHARS)
| Year To Date: | +5.87% | 3-Month: | +0.24% | 3-Year: | +1.45% | 52-Week Range: | 191.59 - 220.18 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.06% | 1-Year: | +12.16% | 5-Year: | +0.14% | Beta vs TA-100: | 1.00 |
Fund Profile & Information for BTSHARS
Harel 4B Equity Track is an open-end fund registered in Israel.
| Inception Date: | 08-21-2001 | Telephone: | 972-3-7616429 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | - | ||
Fundamentals for BTSHARS
| NAV | (on 2013-06-18) 217.95 |
|---|---|
| Assets (M) | (on 2013-05-31) 88.90 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for BTSHARS
No dividends reported
Fees & Expenses for BTSHARS
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 2.00 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for BTSHARS
Filing Date: 02/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Perrigo Co | 15,000 | 6,348,000 | 7.890% |
| Israel Chemicals Ltd | 128,500 | 6,168,000 | 7.666% |
| Teva Pharmaceutical Industries | 42,000 | 5,842,200 | 7.261% |
| KSM Financial - KSM TA Banks | 35,750 | 4,021,875 | 4.999% |
| MEITAV SAL TA BANKS | 342,500 | 3,904,500 | 4.853% |
| Psagot Sal NASDAQ 100 NIS | 130,000 | 3,723,200 | 4.628% |
| Psagot Sal S&P NIS | 22,100 | 3,633,240 | 4.516% |
| Bezeq The Israeli Telecommunic | 557,000 | 2,651,320 | 3.295% |
| Bank Hapoalim BM | 149,960 | 2,469,841 | 3.070% |
| NICE Systems Ltd | 16,000 | 2,131,200 | 2.649% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements

Rate this Page